R
Ri Yao Yang
Researcher at University of Texas MD Anderson Cancer Center
Publications - 36
Citations - 3932
Ri Yao Yang is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Galectin & Immunotherapy. The author has an hindex of 20, co-authored 33 publications receiving 3358 citations. Previous affiliations of Ri Yao Yang include Scripps Research Institute & La Jolla Institute for Allergy and Immunology.
Papers
More filters
Journal ArticleDOI
Galectin-12: A protein associated with lipid droplets that regulates lipid metabolism and energy balance
TL;DR: The results suggest that galectin-12 may be a useful target for treatment of obesity-related metabolic conditions, such as insulin resistance, metabolic syndrome, and type 2 diabetes.
Book ChapterDOI
Analysis of the Intracellular Role of Galectins in Cell Growth and Apoptosis
TL;DR: Methods that are routinely performed in the laboratory to investigate the role of galectins in cell growth and apoptosis are described, including methods for cell isolation, cell maintenance, and genetic manipulations to perturb galectin gene expression.
Journal ArticleDOI
Galectin-12 in Cellular Differentiation, Apoptosis and Polarization.
Lei Wan,Ri Yao Yang,Fu-Tong Liu +2 more
TL;DR: This review discusses the potential clinical applications of modulating the function of galectin-12, a member of a family of mammalian lectins characterized by their affinity for β-galactosides and consensus amino acid sequences.
Journal ArticleDOI
Ultraviolet irradiation promotes FOXP3 transcription via p53 in psoriasis.
TL;DR: It is demonstrated that FOXP3 is regulated, at least in part, by the binding of p53 to several binding sites in the promoter and intron regions following UV irradiation in psoriasis.
Journal ArticleDOI
Galectin-12 inhibits granulocytic differentiation of human NB4 promyelocytic leukemia cells while promoting lipogenesis
TL;DR: It is suggested that galectin‐12 may be a target for treatment of the ATRA‐resistant subset of APL, and data suggest that lipogenesis and other aspects of myeloid differentiation can be differentially regulated.